CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity

Published:2018-03 Issue: Volume:8 Page:41-51
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Kueberuwa Gray,Kalaitsidou Milena,Cheadle Eleanor,Hawkins Robert Edward,Gilham David Edward

Funder

Bloodwise

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference48 articles.

1. Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment;Wang;Protein Cell,2017

2. Driving gene-engineered T cell immunotherapy of cancer;Johnson;Cell Res.,2017

3. CD19-targeted T cells for hematologic malignancies: clinical experience to date;Davila;Cancer J.,2015

4. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N. Engl. J. Med.,2014

5. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia;Davila;Sci. Transl. Med.,2014

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering a solution for allogeneic CAR-T rejection;Molecular Therapy;2024-09

2. IL-21- and CXCL9-engineered GPC3-specific CAR-T cells combined with PD-1 blockade enhance cytotoxic activities against hepatocellular carcinoma;Clinical and Experimental Medicine;2024-08-28

3. Strategies for Improving CAR T Cell Persistence in Solid Tumors;Cancers;2024-08-16

4. A CAR enhancer increases the activity and persistence of CAR T cells;Nature Biotechnology;2024-07-30

5. Effectors of the Future: Universal Chimeric Antigen Receptor;Transfusion Medicine and Hemotherapy;2024-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3